| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Case report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice
Authors:ID Štuhec, Matej (Author)
Files:.pdf RAZ_Stuhec_Matej_2025.pdf (422,74 KB)
MD5: 1269747135910B663F40D7B5B7287FB1
 
URL https://doi.org/10.3389/fpsyt.2025.1677152
 
URL https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1677152/full
 
Language:English
Work type:Scientific work
Typology:1.03 - Other scientific articles
Organization:MF - Faculty of Medicine
Abstract:Introduction: Pharmacotherapy of depression represents a significant challenge in the management of depression in primary care. Although effective treatments have been available, many patients are still not adequately managed. Clinical pharmacists represent one of the possible strategies in the management, although this practice is rarely seen outside the United Kingdom and the United States. Aim: The aim of the case was to evaluate the impact of clinical pharmacist prescribers on depression treatment. Methods: A longitudinal, observational, case-based medication review by a pharmacist prescriber was conducted for a 63-year-old Slovenian patient in a primary care ambulatory setting. The review included three structured medication review assessments performed by a clinical pharmacist prescriber at defined intervals: first observation, two months post-intervention, and six months after first observation. The pharmacists conducted medication reviews and prescribed medications like physicians, operating within a collaborative practice agreement as dependent prescribers. Predefined outcomes included diabetes management (HbA1c and blood glucose), lipid levels (S-LDL), pain (Visual Analogue Scale [VAS]), depression (Patient Health Questionnaire-9 [PHQ-9]), and quality of life (assessed via EQ-5D-VAS). The patient’s complete medication regimens were reviewed, focusing on dosage appropriateness, indication matching, potential drug-drug interactions, and medication adherence. Results: A 63-year-old male Slovenian patient diagnosed with depression, type 2 diabetes with polyneuropathy, and hypothyroidism underwent two medication reviews between December 2024 and July 2025. The pharmacist prescribed amitriptyline and semaglutide (accepted by the patient’s physician). Notable improvements were observed in glycemic control (HbA1c reduced from 9.9% to 8.2%), and quality of life (EQ-5D-VAS score improved from 30/100 to 80/100). Depression symptoms also resolved, with the PHQ-9 score improving from 11 to 4. Conclusions: This case study demonstrates that interventions by a clinical pharmacist prescriber during the medication review process resulted in improved clinical outcomes in the treatment of depression, as well as enhanced quality of life. It represents an important contribution to the development of pharmacist prescribing roles in depression management within primary care settings outside of the United Kingdom and the United States.
Keywords:depression, pharmacist prescriber, clinical pharmacy, ambulatory care, medication review
Publication status:Published
Publication version:Version of Record
Submitted for review:11.08.2025
Article acceptance date:31.07.2025
Publication date:28.08.2025
Publisher:Frontiers
Year of publishing:2025
Number of pages:Str. 1-7
Numbering:Letn. 16, št. članka 1677152
PID:20.500.12556/DKUM-95306 New window
UDC:616.89:615
ISSN on article:1664-0640
COBISS.SI-ID:248512771 New window
DOI:/10.3389/fpsyt.2025.1677152 New window
Publication date in DKUM:15.09.2025
Views:131
Downloads:12
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in psychiatry
Shortened title:Front. psychiatry
Publisher:Frontiers Research Foundation
ISSN:1664-0640
COBISS.SI-ID:54153314 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:V3-24041-2024
Name:Preučitev koristi in tveganj pri odvisnem predpisovanju zdravil v okviru farmacevtske obravnave bolnika

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica